A clinical study on the relationship between drug-resistant tuberculosis (DR-TB) and intestinal microorganisms

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040299

Enrollment

Unknown

Registered

2020-11-27

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug-resistant tuberculosis (DR-TB)

Interventions

sensitive group:none

mono-resistance group:none

MDR-TB group:none

XDR-TB:none

Multidrug resistance group:none

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. Diagnosis of tuberculosis, and drug sensitivity test results are clear; 3. Patients who are willing to participate in this case-control study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or Female patients with family planning during the study period; 2. Suffering from psychosomatic diseases and unable to cooperate; 3. Patients who have done colonoscopy to clean their intestines in the past month; 4. Participated in other drug research in the past three months; 5. Digestive system tumor patients; 6. Patients with history of gastrointestinal surgery; 7. Patients with inflammatory bowel disease; 8. Patients with intestinal obstruction; 9. Patients with gastrointestinal bleeding; 10. Patients with HIV and covid-19.

Design outcomes

Primary

Measure	Time frame
gut microbiota;	—

Countries

China

Contacts

Public ContactShiming Yang

Affiliated Hospital of North Sichuan Medical College

shimingyang@yahoo.com+86 13228686589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026